China SXT Pharmaceuticals (SXTC) Regains Nasdaq Compliance

China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) today announced that on October 19, 2023, NASDAQ notified us that it has determined that for the 10 consecutive business days, from October 5, 2023 to October 13, 2023, the closing bid price of the Company’s ordinary shares has been at $1.00 per share or greater. Accordingly, the Company has regained compliance with Listing Rule 5550(a)(2) and NASDAQ has closed this matter.

You May Also Be Interested In

• Pizza Hut CEO Aaron Powell resigns
• NuRAN Wireless to delist from CSE, keeping Nasdaq listing
• Agilent Technologies filed for proposed debt offering